Clinical Trial Update: Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update for neoadjuvant therapy combining Inituomab, Pyrrolidone, and Nab-paclitaxel in HER2-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Inituomab
• Nab-paclitaxel (paclitaxel protein-bound)
• Pyrrolidone

Snippet

Sponsor: Xijing Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN